Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Wood L, Bassez G, Bleyenheuft C, Campbell C, Cossette L, Jimenez-Moreno AC, Dai Y, Dawkins H, Díaz-Manera J, Dogan C, El Sherif R, Fossati B, Graham C, Hilbert J, Kastreva K, Kimura E, Korngut L, Kostera-Pruszczyk A, Lindberg C, Lindvall B, Luebbe E, Lusakowska A, Mazanec R, Meola G, Orlando L, Takahashi MP, Peric S, Puymirat J, Rakocevic-Stojanovic V, Rodrigues M, Roxburgh R, Schoser B, Segovia S, Shatillo A, Thiele S, Tournev I, van Engelen B, Vohanka S, Lochmüller H.

Orphanet J Rare Dis. 2019 Aug 15;14(1):199. doi: 10.1186/s13023-019-1157-7.

2.

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential.

Chiricozzi A, De Simone C, Fossati B, Peris K.

Psoriasis (Auckl). 2019 May 24;9:29-35. doi: 10.2147/PTT.S179283. eCollection 2019.

3.

A rare case of bullous Sweet's syndrome in a patient with inactive ulcerative colitis.

Esposito I, Fossati B, Peris K, De Simone C.

J Eur Acad Dermatol Venereol. 2019 May 13. doi: 10.1111/jdv.15674. [Epub ahead of print] No abstract available.

PMID:
31081562
4.

Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life.

Caldarola G, De Simone C, Talamonti M, Moretta G, Fossati B, Bianchi L, Fargnoli MC, Peris K.

Eur J Dermatol. 2019 Apr 1;29(2):192-196. doi: 10.1684/ejd.2019.3529.

PMID:
30973328
5.

Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies.

Renna LV, Bosè F, Brigonzi E, Fossati B, Meola G, Cardani R.

PLoS One. 2019 Mar 22;14(3):e0214254. doi: 10.1371/journal.pone.0214254. eCollection 2019.

6.

Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Callus E, Bertoldo EG, Beretta M, Boveri S, Cardani R, Fossati B, Brigonzi E, Meola G.

Front Neurol. 2018 Sep 19;9:751. doi: 10.3389/fneur.2018.00751. eCollection 2018.

7.

Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study.

Chiricozzi A, Giovanardi G, Caposiena Caro DR, Iannone M, De Simone C, Cannizzaro MV, Oranges T, Fossati B, Di Matteo E, Dini V, Bianchi L, Peris K.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06165-5. [Epub ahead of print]

PMID:
30295448
8.

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Wood L, Bassez G, Bleyenheuft C, Campbell C, Cossette L, Jimenez-Moreno AC, Dai Y, Dawkins H, Manera JAD, Dogan C, El Sherif R, Fossati B, Graham C, Hilbert J, Kastreva K, Kimura E, Korngut L, Kostera-Pruszczyk A, Lindberg C, Lindvall B, Luebbe E, Lusakowska A, Mazanec R, Meola G, Orlando L, Takahashi MP, Peric S, Puymirat J, Rakocevic-Stojanovic V, Rodrigues M, Roxburgh R, Schoser B, Segovia S, Shatillo A, Thiele S, Tournev I, van Engelen B, Vohanka S, Lochmüller H.

Orphanet J Rare Dis. 2018 Sep 5;13(1):155. doi: 10.1186/s13023-018-0889-0. Erratum in: Orphanet J Rare Dis. 2019 Aug 15;14(1):199.

9.

SCN4A as modifier gene in patients with myotonic dystrophy type 2.

Binda A, Renna LV, Bosè F, Brigonzi E, Botta A, Valaperta R, Fossati B, Rivolta I, Meola G, Cardani R.

Sci Rep. 2018 Jul 23;8(1):11058. doi: 10.1038/s41598-018-29302-z.

10.

Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature.

Cavalli M, Fossati B, Vitale R, Brigonzi E, Ricigliano VAG, Saraceno L, Cardani R, Pappone C, Meola G.

Front Neurol. 2018 May 30;9:385. doi: 10.3389/fneur.2018.00385. eCollection 2018.

11.

Incidence of amplification failure in DMPK allele due to allelic dropout event in a diagnostic laboratory.

De Siena C, Cardani R, Brigonzi E, Bosè F, Fossati B, Meola G, Costa E, Valaperta R.

Clin Chim Acta. 2018 Sep;484:111-116. doi: 10.1016/j.cca.2018.05.040. Epub 2018 May 24.

PMID:
29803895
12.

Lentigo maligna: diagnosis and treatment.

De Luca EV, Perino F, Di Stefani A, Coco V, Fossati B, Peris K.

G Ital Dermatol Venereol. 2018 Apr 19. doi: 10.23736/S0392-0488.18.06003-0. [Epub ahead of print]

PMID:
29683288
13.

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review.

Ricigliano VAG, Fossati B, Saraceno L, Cavalli M, Bazzigaluppi E, Meola G.

Front Neurosci. 2018 Jan 24;12:17. doi: 10.3389/fnins.2018.00017. eCollection 2018.

14.

Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide.

Valaperta R, De Siena C, Cardani R, Lombardia F, Cenko E, Rampoldi B, Fossati B, Brigonzi E, Rigolini R, Gaia P, Meola G, Costa E, Bugiardini R.

Atherosclerosis. 2017 Dec;267:110-115. doi: 10.1016/j.atherosclerosis.2017.10.020. Epub 2017 Oct 21.

PMID:
29121498
15.

Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle.

Renna LV, Bosè F, Iachettini S, Fossati B, Saraceno L, Milani V, Colombo R, Meola G, Cardani R.

PLoS One. 2017 Sep 15;12(9):e0184987. doi: 10.1371/journal.pone.0184987. eCollection 2017.

16.

Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.

Perfetti A, Greco S, Cardani R, Fossati B, Cuomo G, Valaperta R, Ambrogi F, Cortese A, Botta A, Mignarri A, Santoro M, Gaetano C, Costa E, Dotti MT, Silvestri G, Massa R, Meola G, Martelli F.

Sci Rep. 2017 Feb 22;7:43074. doi: 10.1038/srep43074. No abstract available.

17.

Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1.

Esposito F, Cè E, Rampichini S, Monti E, Limonta E, Fossati B, Meola G.

Eur J Appl Physiol. 2017 Mar;117(3):551-566. doi: 10.1007/s00421-017-3558-4. Epub 2017 Feb 14.

PMID:
28194519
18.

Clinical Reasoning: A 35-year-old woman with hyperstartling, stiffness, and accidental falls: A startling diagnosis.

Russo SP, Fossati B, Toffetti M, Lanzone J, Cardani R, Meola G.

Neurology. 2017 Jan 31;88(5):e38-e41. doi: 10.1212/WNL.0000000000003567. No abstract available.

PMID:
28138086
19.

Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.

Perfetti A, Greco S, Cardani R, Fossati B, Cuomo G, Valaperta R, Ambrogi F, Cortese A, Botta A, Mignarri A, Santoro M, Gaetano C, Costa E, Dotti MT, Silvestri G, Massa R, Meola G, Martelli F.

Sci Rep. 2016 Dec 1;6:38174. doi: 10.1038/srep38174. Erratum in: Sci Rep. 2017 Feb 22;7:43074.

20.

High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: A case-control study.

Valaperta R, Gaeta M, Cardani R, Lombardi F, Rampoldi B, De Siena C, Mori F, Fossati B, Gaia P, Ferraro OE, Villani S, Iachettini S, Piccoli M, Cirillo F, Pusineri E, Meola G, Costa E.

Clin Chim Acta. 2016 Dec 1;463:122-128. doi: 10.1016/j.cca.2016.10.026. Epub 2016 Oct 22.

PMID:
27780717
21.

Combination therapy with hydrogen peroxide (4%), salicylic acid (0.5%) and D-panthenol (4%): efficacy and skyn tolerability in common acne vulgaris during sun exposure period.

Ricci F, Masini F, Fossati B, Frascione P, De Waure C, Capizzi R, Guerriero C.

Eur Rev Med Pharmacol Sci. 2016;20(2):232-6.

22.

Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1.

Iachettini S, Valaperta R, Marchesi A, Perfetti A, Cuomo G, Fossati B, Vaienti L, Costa E, Meola G, Cardani R.

Eur J Histochem. 2015 Oct 26;59(4):2562. doi: 10.4081/ejh.2015.2562.

23.

Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1.

Esposito F, Cè E, Rampichini S, Limonta E, Venturelli M, Monti E, Bet L, Fossati B, Meola G.

Neuromuscul Disord. 2016 Jan;26(1):60-72. doi: 10.1016/j.nmd.2015.09.013. Epub 2015 Sep 25.

24.

Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.

Valaperta R, Lombardi F, Cardani R, Fossati B, Brigonzi E, Merli I, Sansone V, Merletti G, Spina E, Meola G, Costa E.

Genet Test Mol Biomarkers. 2015 Dec;19(12):703-9. doi: 10.1089/gtmb.2015.0135. Epub 2015 Oct 27.

PMID:
26505324
25.

Giant neglected squamous cell carcinoma of the skin.

Ricci F, Paradisi A, Fossati B, Mancini M, Curatolo P, Guerriero C, Capizzi R.

Dermatol Ther. 2015 Jul-Aug;28(4):230-4. doi: 10.1111/dth.12214. Epub 2015 Mar 5.

PMID:
25754304
26.

Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.

Renna LV, Cardani R, Botta A, Rossi G, Fossati B, Costa E, Meola G.

Eur J Histochem. 2014 Oct 22;58(4):2444. doi: 10.4081/ejh.2014.2444.

27.

Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure--efficacy and skin tolerability.

Masini F, Ricci F, Fossati B, Frascione P, Capizzi R, De Waure C, Guerriero C.

Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2283-6.

28.

The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative.

Suppa M, Neri L, Bianchi L, Capizzi R, Carbone A, Catricalà C, Chimenti S, Fargnoli MC, Fossati B, Frascione P, Peris K.

Int J Dermatol. 2015 Jan;54(1):42-9. doi: 10.1111/ijd.12677. Epub 2014 Jul 29.

PMID:
25070362
29.

Melanoma detection in Italian pigmented lesion clinics.

Argenziano G, Moscarella E, Annetta A, Battarra VC, Brunetti B, Buligan C, Cantisani C, Capizzi R, Carbone A, Carlino A, Corsetti V, Damiano A, De Salvo V, De Simone P, Di Caterino P, Fargnoli MC, Ferrari A, Fossati B, Frascione P, Ghigliotti G, González Inchaurraga MA, Guerriero C, Landi C, Mazzoni L, Mirizzi S, Palazzo G, Pedretti A, Peris K, Piemonte P, Rossi A, Satta R, Savoia F, Scalvenzi M, Stanganelli I, Stinco G, Zampieri P, Zalaudek I.

G Ital Dermatol Venereol. 2014 Apr;149(2):161-6.

PMID:
24819635
30.

An unusual case of Koebner phenomenon.

Paradisi A, Ricci F, Fossati B, De Simone C, Capizzi R, Guerriero C.

Eur J Dermatol. 2013 Jul-Aug;23(4):529-30. doi: 10.1684/ejd.2013.2122. No abstract available.

PMID:
24001569
31.

Dermoscopy of melanocytic lesions in patients affected by oculocutaneous albinism: a case series.

Caldarola G, Fania L, Fossati B, Zampetti A, Broganelli P, Massi G, Feliciani C.

Dermatology. 2013;226(4):358-61. doi: 10.1159/000351315. Epub 2013 Jun 29.

PMID:
23816758
32.

Multiple abscesses in a patient treated with cetuximab.

Ricci F, Guerriero C, Paradisi A, Fossati B, Miccichè F, Valentini V, Capizzi R.

Eur J Dermatol. 2013 Jan-Feb;23(1):103-4. doi: 10.1684/ejd.2012.1889. No abstract available.

PMID:
23238287
33.

The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns.

Suppa M, Altomare G, Cannavò SP, Capizzi R, Catricalà C, Colombo E, Fargnoli MC, Fossati B, Frascione P, Lisi P, Santini M, Scalvenzi M, Peris K; Italian investigators for the Euromelanoma prevention campaign.

Int J Dermatol. 2014 Jun;53(6):699-706. doi: 10.1111/j.1365-4632.2012.05783.x. Epub 2012 Dec 11.

PMID:
23230843
34.

Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature.

Castriota M, Ricci F, Paradisi A, Fossati B, De Simone C, Capizzi R, Guerriero C.

Mycoses. 2013 May;56(3):200-3. doi: 10.1111/myc.12020. Epub 2012 Nov 4. Review.

PMID:
23121556
35.

Primitive polypoid granular cell tumor.

Ricci F, Paradisi A, Silveri SL, Fossati B, Pennacchia I, Massi G, Capizzi R, Guerriero C.

Eur J Dermatol. 2012 Jul-Aug;22(4):574-5. doi: 10.1684/ejd.2012.1768. No abstract available.

PMID:
22652435
36.

Acne treatment with isotretinoin in a patient with Apert syndrome.

Paradisi A, Ghitti F, Capizzi R, Fossati B, Amerio PL, Guerriero C.

Eur J Dermatol. 2011 Jul-Aug;21(4):611-2. doi: 10.1684/ejd.2011.1365. No abstract available.

PMID:
21865115
37.

Subcutaneous abscess as a side-effect of cetuximab therapy.

Guerriero C, Ricci F, Paradisi A, Fossati B, Valentini V, Pacelli F, Capizzi R.

Eur J Dermatol. 2011 Mar-Apr;21(2):277-8. doi: 10.1684/ejd.2010.1231. No abstract available.

PMID:
21382780
38.

Extragenital lichen sclerosus and atrophicus treated with topical steroids and retinoids in a child with vitiligo.

Guerriero C, Manco S, Paradisi A, Capizzi R, Fossati B, Fabrizi G.

Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):757-9.

PMID:
18831946
39.

Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy: case report.

Guerriero C, Lanza Silveri S, Sisto T, Rosati D, De Simone C, Fossati B, Pomini F, Rotoli M, Amerio P, Capizzi R.

J Biol Regul Homeost Agents. 2008 Apr-Jun;22(2):141-4.

PMID:
18597707
40.

Use of acitretin in a case of giant common warts in an HIV-infected patient.

Simone CD, Capizzi R, Carbone A, Fossati B, Valenzano F, Amerio P.

Eur J Dermatol. 2008 May-Jun;18(3):346-7. doi: 10.1684/ejd.2008.0406. Epub 2008 May 13. No abstract available.

PMID:
18474473
41.

Malignant melanoma in a tattoo: case report and review of the literature.

Paradisi A, Capizzi R, De Simone C, Fossati B, Proietti I, Amerio PL.

Melanoma Res. 2006 Aug;16(4):375-6.

PMID:
16845335
42.

High prevalence of celiac disease in psoriasis.

Ojetti V, Aguilar Sanchez J, Guerriero C, Fossati B, Capizzi R, De Simone C, Migneco A, Amerio P, Gasbarrini G, Gasbarrini A.

Am J Gastroenterol. 2003 Nov;98(11):2574-5. No abstract available.

PMID:
14638373

Supplemental Content

Loading ...
Support Center